Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan

Taiwanese Journal of Obstetrics and Gynecology

Volumn 52, Issue 1, 2013, Pages 81-84

  Chao, Kuan Chong ^a,b   Chen, Yi Jen ^a,b   Juang, Chi Mou ^a,b   Lau, Hei Yu ^a,b   Wen, Kuo Chang ^a,b   Sung, Pi Lin ^a,b   Fang, Feng Ying ^a,b   Twu, Nae Fang ^a,b   Yen, Ming Shyen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Ovarian cancer; Primary peritoneal serous papillary carcinoma; Prognosis

Indexed keywords

PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PERITONEAL SEROUS PAPILLARY CARCINOMA; PERITONEUM CANCER; PROGRESSION FREE SURVIVAL; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAIWAN;

EID: 84878013808     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2012.10.003     Document Type: Article

References (21)

1. Dubernard G., Morice P., Rey A., Camatte S., Pautier P., Lhommé C., et al. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma. Gynecol Oncol 2005, 97:136-141.
2. Fromm G.L., Gershenson D.M., Silva E.G. Papillary serous carcinoma of the peritoneum. Obstet Gynecol 1990, 75:89-95.
3. Dalrymple J.C., Bannatyne P., Russell P., Solomon H.J., Tattersall M.H., Atkinson K., et al. Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 1989, 64:110-115.
4. Ben-Baruch G., Sivan E., Moran O., Rizel S., Menczer J., Seidman D.S. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Gynecol Oncol 1996, 60:393-396.
5. Piura B., Meirovitz M., Bartfeld M., Yanai-Inbar I., Cohen Y. Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma. J Surg Oncol 1998, 68:173-178.
6. Bloss J.D., Liao S.Y., Buller R.E., Manetta A., Berman M.L., McMeekin S., et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 1993, 50:347-351.
7. Halperin R., Zehavi S., Langer R., Hadas E., Bukovsky I., Schneider D. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 2001, 11:403-408.
8. Killackey M.A., Davis A.R. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma. Gynecol Oncol 1993, 51:171-174.
9. Dubernard G., Morice P., Rey A., Camatte S., Fourchotte V., Thoury A., et al. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma. Eur J Surg Oncol 2004, 30:976-981.
10. Chen L.M., Yamada S.D., Fu Y.S., Baldwin R.L., Karlan B.Y. Molecular similarities between primary peritoneal and primary ovarian carcinomas. Int J Gynecol Cancer 2003, 13:749-755.
11. Biagi J.J., Oza A.M., Chalchal H.I., Grimshaw R., Ellard S.L., Lee U., et al. A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study. Ann Oncol 2011, 22:335-340.
12. Mulhollan T.J., Silva E.G., Tornos C., Guerrieri C., Fromm G.L., Gershenson D. Ovarian involvement by serous surface papillary carcinoma. Int J Gynecol Pathol 1994, 13:120-126.
13. Wang P.H., Shyong W.Y., Li Y.F., Lee H.H., Tsai W.Y., Chao H.T., et al. BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma. Jpn J Clin Oncol 2000, 30:343-348.
14. Jordan S.J., Green A.C., Whiteman D.C., Moore S.P., Bain C.J., Gertig D.M., et al. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 2008, 122:1598-1603.
15. Schmeler K.M., Sun C.C., Malpica A., Deavers M.T., Bodurka D.C., Gershenson D.M. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol 2011, 121:482-486.
16. du Bois A., Quinn M., Thigpen T., Vermorken J., Avall-Lundqvist E., Bookman M., et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005, 16(Suppl. 8):viii7-viii12.
17. Alberts D.S., Liu P.Y., Hannigan E.V., O'Toole R., Williams S.D., Young J.A., et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996, 335:1950-1955.
18. Armstrong D.K., Bundy B., Wenzel L., Huang H.Q., Baergen R., Lele S., et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006, 354:34-43.
19. Miyagi Y., Fujiwara K., Kigawa J., Itamochi H., Nagao S., Aotani E., et al. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin - a Sankai Gynecology Study Group (SGSG) study. Gynecol Oncol 2005, 99:591-596.
20. Liu J., Li M. The study of platinum concentration in retroperitoneal lymph nodes after intraperitoneal carboplatin in ovarian tumors. Zhonghua Fu Chan Ke Za Zhi 1995, 30:273-275.
21. Chiou S.Y., Sheu M.H., Wang J.H., Chang C.Y. Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review. Abdom Imaging 2003, 28:815-819.